FITLIFE BRANDS, INC. (FTLF) Q3 2025 10-Q Quarterly Report
Filed: Nov 13, 2025Period ending Sep 30, 2025
Health Care
Medicinal Chemicals & Botanical ProductsSEC EDGAR FITLIFE BRANDS, INC. (FTLF) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 13, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
FITLIFE BRANDS, INC. Q3 2025 10-Q Analysis
Risk Factors
- • No material changes to risk factors since 2024 10-K filing on March 27, 2025
- • Competitive pressure from established brands remains significant risk to market share and revenue growth
FITLIFE BRANDS, INC. Q3 2025 Quarterly FinancialsXBRL
Revenue
$23M
▲ +47.0% YoY▲ +45.6% QoQ
Net Income
$921,000
▼ -56.7% YoY▼ -47.3% QoQ
Gross Margin
37.2%
▼ -662bp YoY▼ -561bp QoQ
Operating Margin
9.9%
▼ -1005bp YoY▼ -574bp QoQ
Net Margin
3.9%
▼ -938bp YoY▼ -691bp QoQ
ROE
2.2%
Total Assets
$110M
EPS (Diluted)
$0.09
▼ -79.1% YoY▼ -50.0% QoQ
Operating Cash Flow
$4M
▲ +79.4% YoY▲ +207.3% QoQ
Source: XBRL data from FITLIFE BRANDS, INC. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on FITLIFE BRANDS, INC.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.